Target Audience: Actual and prospective company founders;  chief executive officers; science and technology innovators interested in starting a company; technology-transfer officers at universities and research laboratories; angel and venture capital investors focusing on health-care innovation Industries Covered Early-stage technology companies whose intellectual property innovations address significantly underserved patient treatment, care provider capability, or payer-population risk management challenges in the health-care system. Including:  "smart” medical devices that incorporate software-based added value to clinicians – treatment-decision support platforms, analytics, and diagnostics – care-provider workflow coordination and optimization solutions that bring artificial intelligence and other technologies – emerging technologies that are widely used elsewhere, but are new to health care. Target Company Size Ranging from pre-formation and in the planning stage to early operational stage. Includes early revenue companies (under $5 million ) that are “stuck,” and seeking strategic and tactical market development support.